Moonlight wrote:
View original post
Having studied in US, Jews are overwhelming STEM researchers any ways...
Take a good look at Biotech companies operating out of Israel
biopharmguy.com/links/company-by-name-israel.php
No surprise that a lot of cutting edge research is coming out of Israel, no conspiracy there.
Teva started all this of course...
www.pharmaceutical-technology.com/features/featurepharma-...
Quote:
For many years, Israel’s pharmaceutical and biotechnology sectors have been used to punching above their weight. Despite the country’s relative youth as an independent state and a history of geopolitical tension, its health and life sciences industries have emerged as a jewel of the Middle East, with rapid expansion in many fields driven by a strong academic underpinning, world-class research facilities and high spending in research and development (R&D).
The Israeli pharma market, which is broadly composed of generics giant Teva Pharmaceutical Industries and a host of smaller, R&D-driven biotech companies, is healthy and growing for a number of reasons. The country’s high population density and relatively youthful demographics provide plenty of young talent, meaning Israel hosts one of the highest rates of high-tech start-ups per capita in the world.
But the story of Israel’s pharmaceutical industry undoubtedly starts with Teva, the undisputed colossus of the industry, which has developed into one of the largest pharma companies in the world today, one that is expected to achieve sales worth $26bn in 2016.
“When you talk about pharmaceuticals in Israel, you have to talk about Teva,” says Steven Tepper, senior research analyst for pharmaceuticals and biotechnology at Tel Aviv-based IBI Investment House. “Teva Pharmaceutical is the company. There are a few other smaller companies, but Teva is the major company with the richest history.”
The Israeli pharma market, which is broadly composed of generics giant Teva Pharmaceutical Industries and a host of smaller, R&D-driven biotech companies, is healthy and growing for a number of reasons. The country’s high population density and relatively youthful demographics provide plenty of young talent, meaning Israel hosts one of the highest rates of high-tech start-ups per capita in the world.
But the story of Israel’s pharmaceutical industry undoubtedly starts with Teva, the undisputed colossus of the industry, which has developed into one of the largest pharma companies in the world today, one that is expected to achieve sales worth $26bn in 2016.
“When you talk about pharmaceuticals in Israel, you have to talk about Teva,” says Steven Tepper, senior research analyst for pharmaceuticals and biotechnology at Tel Aviv-based IBI Investment House. “Teva Pharmaceutical is the company. There are a few other smaller companies, but Teva is the major company with the richest history.”
I just wish that the amount of time we Muslims spend in theories, we should spend in STEM to get ahead.

